Studying metabolic disease? The streptozotocin-induced diabetic rat model supports evaluation of disease progression and therapeutic response in a controlled, reproducible setting. Read the full whitepaper 👉 https://buff.ly/ib2WOQP #diabetes #research #lifesciences
Noble Life Sciences Inc
Biotechnology
Preclinical CRO-in vitro and in vivo testing services for cell and gene therapy, biologics, vaccines, drugs, and devices
About us
Noble Life Sciences is a contract research organization (CRO) that provides a full continuum of preclinical drug, vaccine and medical device development services, from initial product discovery to GLP-compliant studies. Our services are designed to help you advance from concept to clinic faster and more efficiently. Noble's state-of-the-art facilities are located in Sykesville, MD in the BioHealth Capital Region. We offer integrated in vitro and in vivo services, including cellular and animal disease model development and experimental design, efficacy, toxicity, biodistribution and product release studies in both small and large animals. Managed by industry experts with years of experience in animal care, Noble's vivarium services group is ready to support your in vivo R&D: we provide custom housing, husbandry, and breeding; facility and program management; and high-level implementation of preclinical drug development services. Noble also offers custom antibody production services as well as tissue and animal sourcing. With an emphasis on quality, our proof-of- concept studies, early safety assessments and other pre-IND services are sure to provide a strong scientific foundation for your preclinical decisions. Noble’s key advantages are our deep expertise and the years of experience of our scientific team, who bring their insights to optimize and expedite our customers’ preclinical studies. With our quality control and expertise in cell- & animal-based models, you can trust Noble scientists to help lead and support your development programs through each phase of the preclinical process.
- Website
-
http://www.noblelifesci.com
External link for Noble Life Sciences Inc
- Industry
- Biotechnology
- Company size
- 11-50 employees
- Headquarters
- Washington DC-Baltimore Area
- Type
- Privately Held
- Founded
- 2010
- Specialties
- Preclinical cellular- and animal-based disease models, Preclinical drug development CRO, Oncology xenograft models, Vivarium services, GLP and non-GLP preclinical studies, Large and small animal models, Polyclonal antibodies, Medical Devices, Infectious Disease Models, Cell & Gene Therapy, Live animal IVIS imaging, Wound models, Orthopedic , Cardiovascular, Ophthalmology, Flow Cytometry, Assay Development, and Custom Model Development
Locations
-
Primary
Get directions
Washington DC-Baltimore Area , 21797, US
-
Get directions
PO Box 242
Woodbine, MD 21797, US
Employees at Noble Life Sciences Inc
Updates
-
Oncology programs move fast, and the need for clear, actionable data does not stop when a study ends. We support oncology teams by going beyond model execution. It is about continuing to provide insight, context, and collaboration as decisions evolve. Because it is more than a model. It is a partnership. https://buff.ly/wBAXepY #oncologycro #cancerresearch
-
-
In preclinical research, every insight begins with a step into the unknown. That is where real progress happens. #mondaymotivation
-
-
Researchers at John Hopkins University and the University of Maryland School of Pharmacy, developed first-in-class dual HIF-1/2 inhibitors that target key drivers of tumor growth and immune evasion. When combined with immune checkpoint therapies, these compounds led to complete tumor remission in multiple cancer types in mice, including breast, colorectal, melanoma, and prostate. Read the full study to explore the findings 👉https://lnkd.in/gKwSc8qk #cancer #oncology #immune
-
-
A “paradox” cancer mutation may be opening new paths for combination therapies. Researchers studying BAP1, a gene linked to multiple aggressive cancers, identified new drug targets that disrupt DNA repair mechanisms. In preclinical models, combining LSD1 and PARP inhibitors led to tumor reduction and improved survival across several cancer types. As more therapies move toward combination strategies, studies like this highlight how understanding underlying biology can unlock broader treatment approaches. 👉 https://buff.ly/nnGxr3O Duke-NUS Medical School #lifesciences #cancerresearch
-
-
Did you know? Non-invasive imaging plays a key role in generating more complete, decision-ready data in preclinical studies. 🔬 Live animal imaging with the IVIS Lumina LT III provides real-time insight into efficacy, kinetics, target engagement, and mechanism of action within the same study. This approach supports: • longitudinal tracking of disease progression and treatment response • simultaneous measurement of infection and host response • fewer cohorts through repeat imaging It is particularly valuable in oncology and infectious disease studies, where understanding changes over time can inform more confident decisions. 👇🏻 Take a closer look at the full capabilities below. #oncology #infectiousdisease #imaging
-
Strong outcomes don’t happen by accident. They start with the right foundation. And that foundation is preclinical strategy. Preclinical success starts here👉 noblelifesci.com #preclinicalcro #lifesciences
-
The FDA’s Office of Clinical Pharmacology has released its 2025 Annual Report, highlighting ongoing efforts to advance #drugdevelopment through clinical pharmacology and #translationalscience. ‼️Updates like this reflect the continued importance of aligning research and data across the development lifecycle. Read the full report below. 👇🏻
Today, the U.S. Food and Drug Administration's Office of Clinical Pharmacology (OCP) announced the availability of the 2025 OCP Annual Report. OCP is a dynamic, purpose-driven organization dedicated to promoting and protecting global public health through the application of clinical pharmacology and translational medicine principles. To learn more, visit: https://lnkd.in/eeXb3BxF
-
We’re hiring an Animal Care Technician to join our team at Noble Life Sciences Inc. This role plays an important part in supporting preclinical research by ensuring the health, care, and well-being of research animals while maintaining high standards across our facility. If you are detail-oriented, care deeply about animal welfare, and enjoy working in a collaborative, science-driven environment, this could be a great opportunity to grow your career. To apply, email your resume to: khaslbeck@noblelifesci.com #marylandjobs #nowhiring #labjob
-
-
April 7th is World Health Day, a reminder that improving global health takes more than innovation. This year’s focus on universal health coverage reinforces an important idea that quality healthcare should be accessible to everyone, everywhere. 🌎️ We are proud to support the research behind new therapies that help make that possible. #worldhealthday #publichealth
-
